

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 6.96653237 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 6.96653237 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.50193169 |
| 4 | intestinal epithelial cell development (GO:0060576) | 5.42127148 |
| 5 | protein retention in ER lumen (GO:0006621) | 5.10643459 |
| 6 | COPII vesicle coating (GO:0048208) | 4.71035313 |
| 7 | signal peptide processing (GO:0006465) | 4.69417547 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 4.56570798 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.56570798 |
| 10 | positive regulation of keratinocyte differentiation (GO:0045618) | 4.50032949 |
| 11 | intestinal cholesterol absorption (GO:0030299) | 4.46188574 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.42579201 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 4.42579201 |
| 14 | ear development (GO:0043583) | 4.39214777 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.16821987 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.16821987 |
| 17 | valine metabolic process (GO:0006573) | 4.08965870 |
| 18 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.08909592 |
| 19 | amyloid precursor protein catabolic process (GO:0042987) | 4.04733033 |
| 20 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 4.02796227 |
| 21 | * activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.02130554 |
| 22 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.92672348 |
| 23 | complement activation, classical pathway (GO:0006958) | 3.91314222 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 3.87136786 |
| 25 | * positive regulation of nuclease activity (GO:0032075) | 3.83689884 |
| 26 | proline biosynthetic process (GO:0006561) | 3.82996169 |
| 27 | 4-hydroxyproline metabolic process (GO:0019471) | 3.81704699 |
| 28 | protein carboxylation (GO:0018214) | 3.75677168 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.75677168 |
| 30 | alpha-linolenic acid metabolic process (GO:0036109) | 3.72981835 |
| 31 | * endoplasmic reticulum unfolded protein response (GO:0030968) | 3.71908648 |
| 32 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.70729911 |
| 33 | maternal placenta development (GO:0001893) | 3.66395484 |
| 34 | vagina development (GO:0060068) | 3.65463209 |
| 35 | aromatic amino acid family catabolic process (GO:0009074) | 3.65306906 |
| 36 | primary alcohol catabolic process (GO:0034310) | 3.64635253 |
| 37 | uterus development (GO:0060065) | 3.62427227 |
| 38 | GDP-mannose metabolic process (GO:0019673) | 3.61075114 |
| 39 | cysteine metabolic process (GO:0006534) | 3.60632691 |
| 40 | regulation of water loss via skin (GO:0033561) | 3.60119594 |
| 41 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.59526202 |
| 42 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.59240054 |
| 43 | * cellular response to unfolded protein (GO:0034620) | 3.57264681 |
| 44 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.55823061 |
| 45 | complement activation (GO:0006956) | 3.53707731 |
| 46 | complement activation, alternative pathway (GO:0006957) | 3.52838981 |
| 47 | vitamin transmembrane transport (GO:0035461) | 3.52351305 |
| 48 | hepatocyte apoptotic process (GO:0097284) | 3.47421647 |
| 49 | * regulation of nuclease activity (GO:0032069) | 3.46498893 |
| 50 | * ER-nucleus signaling pathway (GO:0006984) | 3.46058227 |
| 51 | ER overload response (GO:0006983) | 3.45387224 |
| 52 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.39587084 |
| 53 | * cellular response to topologically incorrect protein (GO:0035967) | 3.39073652 |
| 54 | protein maturation by protein folding (GO:0022417) | 3.37543222 |
| 55 | transcytosis (GO:0045056) | 3.36430817 |
| 56 | negative regulation of fibrinolysis (GO:0051918) | 3.35972687 |
| 57 | high-density lipoprotein particle remodeling (GO:0034375) | 3.35118906 |
| 58 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.32541882 |
| 59 | multicellular organismal water homeostasis (GO:0050891) | 3.31842452 |
| 60 | ethanol metabolic process (GO:0006067) | 3.30956563 |
| 61 | regulation of protein activation cascade (GO:2000257) | 3.30725514 |
| 62 | regulation of keratinocyte differentiation (GO:0045616) | 3.30530357 |
| 63 | desmosome organization (GO:0002934) | 3.30390495 |
| 64 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.29598478 |
| 65 | regulation of cholesterol homeostasis (GO:2000188) | 3.28941769 |
| 66 | negative regulation of cell size (GO:0045792) | 3.28183536 |
| 67 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.25811785 |
| 68 | sequestering of metal ion (GO:0051238) | 3.25468259 |
| 69 | glyoxylate metabolic process (GO:0046487) | 3.22737443 |
| 70 | interferon-gamma secretion (GO:0072643) | 3.20911503 |
| 71 | reverse cholesterol transport (GO:0043691) | 3.20773224 |
| 72 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.20466489 |
| 73 | * response to endoplasmic reticulum stress (GO:0034976) | 3.20040290 |
| 74 | vesicle coating (GO:0006901) | 3.19919895 |
| 75 | lysine catabolic process (GO:0006554) | 3.19684547 |
| 76 | lysine metabolic process (GO:0006553) | 3.19684547 |
| 77 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.18469501 |
| 78 | peptidyl-asparagine modification (GO:0018196) | 3.16830185 |
| 79 | regulation of complement activation (GO:0030449) | 3.15488887 |
| 80 | regulation of interleukin-13 production (GO:0032656) | 3.13284486 |
| 81 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.13186132 |
| 82 | mammary gland epithelial cell differentiation (GO:0060644) | 3.11702025 |
| 83 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.11453100 |
| 84 | intestinal absorption (GO:0050892) | 3.10286057 |
| 85 | kynurenine metabolic process (GO:0070189) | 3.09999825 |
| 86 | cellular zinc ion homeostasis (GO:0006882) | 3.08555518 |
| 87 | homocysteine metabolic process (GO:0050667) | 3.07873609 |
| 88 | protein activation cascade (GO:0072376) | 3.07844147 |
| 89 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.06554058 |
| 90 | regulation of histone H3-K27 methylation (GO:0061085) | 3.06532688 |
| 91 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 3.05795659 |
| 92 | bile acid biosynthetic process (GO:0006699) | 3.05255902 |
| 93 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 3.02534027 |
| 94 | urea cycle (GO:0000050) | 3.01542577 |
| 95 | urea metabolic process (GO:0019627) | 3.01542577 |
| 96 | apoptotic cell clearance (GO:0043277) | 3.01453213 |
| 97 | proline metabolic process (GO:0006560) | 2.99046771 |
| 98 | regulation of triglyceride catabolic process (GO:0010896) | 2.98823184 |
| 99 | tricarboxylic acid metabolic process (GO:0072350) | 2.98517047 |
| 100 | tryptophan metabolic process (GO:0006568) | 2.97535535 |
| 101 | regulation of fibrinolysis (GO:0051917) | 2.97496656 |
| 102 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.96836011 |
| 103 | tryptophan catabolic process (GO:0006569) | 2.96273095 |
| 104 | indole-containing compound catabolic process (GO:0042436) | 2.96273095 |
| 105 | indolalkylamine catabolic process (GO:0046218) | 2.96273095 |
| 106 | trophectodermal cell differentiation (GO:0001829) | 2.96260511 |
| 107 | cellular modified amino acid catabolic process (GO:0042219) | 2.95726143 |
| 108 | acylglycerol homeostasis (GO:0055090) | 2.94452287 |
| 109 | triglyceride homeostasis (GO:0070328) | 2.94452287 |
| 110 | * exocrine pancreas development (GO:0031017) | 2.93772085 |
| 111 | mammary gland alveolus development (GO:0060749) | 2.92975348 |
| 112 | protein N-linked glycosylation (GO:0006487) | 2.92785725 |
| 113 | plasma lipoprotein particle clearance (GO:0034381) | 2.92668653 |
| 114 | nitric oxide biosynthetic process (GO:0006809) | 2.92131278 |
| 115 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.91984392 |
| 116 | phospholipid efflux (GO:0033700) | 2.91895972 |
| 117 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.89314689 |
| 118 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.88210229 |
| 119 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.86332828 |
| 120 | endocrine pancreas development (GO:0031018) | 2.86170875 |
| 121 | acute-phase response (GO:0006953) | 2.85958492 |
| 122 | plasma lipoprotein particle remodeling (GO:0034369) | 2.82237940 |
| 123 | protein-lipid complex remodeling (GO:0034368) | 2.82237940 |
| 124 | macromolecular complex remodeling (GO:0034367) | 2.82237940 |
| 125 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.80202718 |
| 126 | nitrogen cycle metabolic process (GO:0071941) | 2.78072033 |
| 127 | response to food (GO:0032094) | 2.73889900 |
| 128 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.73500813 |
| 129 | water homeostasis (GO:0030104) | 2.73358967 |
| 130 | phospholipid homeostasis (GO:0055091) | 2.71784889 |
| 131 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.71107397 |
| 132 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.71107397 |
| 133 | bile acid metabolic process (GO:0008206) | 2.71058576 |
| 134 | * response to unfolded protein (GO:0006986) | 2.70973667 |
| 135 | peptide catabolic process (GO:0043171) | 2.70221939 |
| 136 | branched-chain amino acid metabolic process (GO:0009081) | 2.70214845 |
| 137 | amyloid precursor protein metabolic process (GO:0042982) | 2.70156140 |
| 138 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.70098118 |
| 139 | biotin metabolic process (GO:0006768) | 2.69751979 |
| 140 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.68869113 |
| 141 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.68573327 |
| 142 | low-density lipoprotein particle clearance (GO:0034383) | 2.67810457 |
| 143 | 2-oxoglutarate metabolic process (GO:0006103) | 2.66985014 |
| 144 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.66575675 |
| 145 | surfactant homeostasis (GO:0043129) | 2.66451361 |
| 146 | aromatic amino acid family metabolic process (GO:0009072) | 2.65642729 |
| 147 | purine nucleotide transport (GO:0015865) | 2.64973759 |
| 148 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.64728127 |
| 149 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.64535527 |
| 150 | glandular epithelial cell differentiation (GO:0002067) | 2.64071393 |
| 151 | * response to topologically incorrect protein (GO:0035966) | 2.63742311 |
| 152 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.63334104 |
| 153 | lipoprotein metabolic process (GO:0042157) | 2.62599053 |
| 154 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.62262980 |
| 155 | epoxygenase P450 pathway (GO:0019373) | 2.62229438 |
| 156 | striated muscle atrophy (GO:0014891) | 2.61940850 |
| 157 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.61169770 |
| 158 | benzene-containing compound metabolic process (GO:0042537) | 2.60862005 |
| 159 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.59985207 |
| 160 | norepinephrine metabolic process (GO:0042415) | 2.56281182 |
| 161 | negative regulation of fatty acid transport (GO:2000192) | 2.53602315 |
| 162 | zinc ion transmembrane transport (GO:0071577) | 2.51590271 |
| 163 | regulation of autophagic vacuole assembly (GO:2000785) | 2.50963169 |
| 164 | amino-acid betaine transport (GO:0015838) | 2.49779528 |
| 165 | carnitine transport (GO:0015879) | 2.49779528 |
| 166 | establishment of skin barrier (GO:0061436) | 2.49019841 |
| 167 | embryonic process involved in female pregnancy (GO:0060136) | 2.48794199 |
| 168 | female genitalia development (GO:0030540) | 2.47460965 |
| 169 | phosphate ion homeostasis (GO:0055062) | 2.46174828 |
| 170 | trivalent inorganic anion homeostasis (GO:0072506) | 2.46174828 |
| 171 | endothelial cell chemotaxis (GO:0035767) | 2.44682120 |
| 172 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.43881165 |
| 173 | mammary gland epithelial cell proliferation (GO:0033598) | 2.43564116 |
| 174 | purine ribonucleotide transport (GO:0015868) | 2.42611271 |
| 175 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.40262886 |
| 176 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.38035399 |
| 177 | pinocytosis (GO:0006907) | 2.38009604 |
| 178 | quaternary ammonium group transport (GO:0015697) | 2.35848129 |
| 179 | positive regulation of hormone metabolic process (GO:0032352) | 2.35822994 |
| 180 | prostate gland growth (GO:0060736) | 2.34686919 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.97482435 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.18023081 |
| 3 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 5.13109332 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.72977995 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.02657116 |
| 6 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.97465775 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.90271839 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.30122493 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.25103215 |
| 10 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 3.14253793 |
| 11 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.98880556 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.97706882 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.84383306 |
| 14 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.60605127 |
| 15 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 2.52346984 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.51546934 |
| 17 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.49491144 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.42815027 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.31102211 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.30501420 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.21295644 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.96960112 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.92743276 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.89985379 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.89084579 |
| 26 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.84129811 |
| 27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.78207821 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.78012254 |
| 29 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.76608675 |
| 30 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.60817990 |
| 31 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.60113147 |
| 32 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.57313718 |
| 33 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.55545989 |
| 34 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52178169 |
| 35 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.48623946 |
| 36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.45946836 |
| 37 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45078774 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39996686 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39913707 |
| 40 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.38797953 |
| 41 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36531681 |
| 42 | MYC_22102868_ChIP-Seq_BL_Human | 1.36022735 |
| 43 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.34464079 |
| 44 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.33750943 |
| 45 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.32529040 |
| 46 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32320366 |
| 47 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.31311401 |
| 48 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.30235185 |
| 49 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.29592250 |
| 50 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28010609 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.27590918 |
| 52 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.27581104 |
| 53 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.27194322 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26124232 |
| 55 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.25771810 |
| 56 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.20250203 |
| 57 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19980139 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.19777221 |
| 59 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19370307 |
| 60 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.18921159 |
| 61 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.18007261 |
| 62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17879732 |
| 63 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.17008484 |
| 64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16060893 |
| 65 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.15680516 |
| 66 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.15476589 |
| 67 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15134696 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13993373 |
| 69 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.12882999 |
| 70 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11874576 |
| 71 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.11731181 |
| 72 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11696350 |
| 73 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.10456844 |
| 74 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.09756188 |
| 75 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.09517085 |
| 76 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.09019560 |
| 77 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.08617312 |
| 78 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08550731 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07978715 |
| 80 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.07756449 |
| 81 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.06974824 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06644866 |
| 83 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02942105 |
| 84 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02142658 |
| 85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01155990 |
| 86 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.00447037 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00395533 |
| 88 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.00272010 |
| 89 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00152010 |
| 90 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.98429556 |
| 91 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97292566 |
| 92 | * VDR_21846776_ChIP-Seq_THP-1_Human | 0.97239728 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96673076 |
| 94 | P68_20966046_ChIP-Seq_HELA_Human | 0.96366909 |
| 95 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95889714 |
| 96 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.95470448 |
| 97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95384317 |
| 98 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.95069969 |
| 99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94669072 |
| 100 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.93886867 |
| 101 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.93565419 |
| 102 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92325070 |
| 103 | * MAF_26560356_Chip-Seq_TH1_Human | 0.92277389 |
| 104 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91960329 |
| 105 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91778667 |
| 106 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91725926 |
| 107 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.91337008 |
| 108 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90916060 |
| 109 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.88831330 |
| 110 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.88694449 |
| 111 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88515091 |
| 112 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88480298 |
| 113 | MYB_26560356_Chip-Seq_TH2_Human | 0.88115344 |
| 114 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.87918218 |
| 115 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.87566472 |
| 116 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86895962 |
| 117 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.85717959 |
| 118 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85518047 |
| 119 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85043144 |
| 120 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84384915 |
| 121 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.82774091 |
| 122 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.82649821 |
| 123 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82500111 |
| 124 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.82497953 |
| 125 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81034550 |
| 126 | UTX_26944678_Chip-Seq_JUKART_Human | 0.80305158 |
| 127 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.80089478 |
| 128 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.79284273 |
| 129 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.78412817 |
| 130 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.78302361 |
| 131 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.78152784 |
| 132 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.77702190 |
| 133 | * MYB_26560356_Chip-Seq_TH1_Human | 0.76448535 |
| 134 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76160605 |
| 135 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.75685326 |
| 136 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.75685326 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74811043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.70213817 |
| 2 | MP0005365_abnormal_bile_salt | 4.40245143 |
| 3 | MP0005360_urolithiasis | 3.96735209 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.64034594 |
| 5 | MP0005083_abnormal_biliary_tract | 3.28508538 |
| 6 | MP0001666_abnormal_nutrient_absorption | 3.19173497 |
| 7 | MP0003195_calcinosis | 2.80595572 |
| 8 | MP0005220_abnormal_exocrine_pancreas | 2.54660664 |
| 9 | MP0003252_abnormal_bile_duct | 2.54581752 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.50367664 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.48621224 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.45125287 |
| 13 | MP0009840_abnormal_foam_cell | 2.36081197 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.31430697 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.27536069 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.23288683 |
| 17 | MP0002098_abnormal_vibrissa_morphology | 2.11860378 |
| 18 | MP0005076_abnormal_cell_differentiation | 2.05318791 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.98558989 |
| 20 | MP0006054_spinal_hemorrhage | 1.95055162 |
| 21 | MP0000627_abnormal_mammary_gland | 1.94875135 |
| 22 | MP0010678_abnormal_skin_adnexa | 1.81308870 |
| 23 | MP0005451_abnormal_body_composition | 1.79482500 |
| 24 | MP0002877_abnormal_melanocyte_morpholog | 1.79367263 |
| 25 | MP0003868_abnormal_feces_composition | 1.78249474 |
| 26 | MP0005058_abnormal_lysosome_morphology | 1.77146553 |
| 27 | MP0002693_abnormal_pancreas_physiology | 1.77055417 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.74099959 |
| 29 | MP0005332_abnormal_amino_acid | 1.72906837 |
| 30 | MP0002009_preneoplasia | 1.71762171 |
| 31 | MP0001944_abnormal_pancreas_morphology | 1.71647171 |
| 32 | * MP0000609_abnormal_liver_physiology | 1.71256450 |
| 33 | MP0000013_abnormal_adipose_tissue | 1.71213179 |
| 34 | MP0001727_abnormal_embryo_implantation | 1.71118689 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.70499609 |
| 36 | MP0005408_hypopigmentation | 1.68910504 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.67764993 |
| 38 | MP0003705_abnormal_hypodermis_morpholog | 1.66677239 |
| 39 | MP0000383_abnormal_hair_follicle | 1.59522792 |
| 40 | MP0003436_decreased_susceptibility_to | 1.48977427 |
| 41 | MP0005501_abnormal_skin_physiology | 1.48532069 |
| 42 | MP0005319_abnormal_enzyme/_coenzyme | 1.45176726 |
| 43 | MP0004019_abnormal_vitamin_homeostasis | 1.44685746 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.42253987 |
| 45 | MP0003724_increased_susceptibility_to | 1.41629131 |
| 46 | MP0001881_abnormal_mammary_gland | 1.41457226 |
| 47 | MP0004381_abnormal_hair_follicle | 1.39922118 |
| 48 | MP0003303_peritoneal_inflammation | 1.34467391 |
| 49 | MP0002132_abnormal_respiratory_system | 1.33830692 |
| 50 | MP0002006_tumorigenesis | 1.33437424 |
| 51 | MP0002078_abnormal_glucose_homeostasis | 1.33241167 |
| 52 | MP0003763_abnormal_thymus_physiology | 1.29702387 |
| 53 | MP0010368_abnormal_lymphatic_system | 1.29298381 |
| 54 | MP0005084_abnormal_gallbladder_morpholo | 1.29234229 |
| 55 | MP0000462_abnormal_digestive_system | 1.28726286 |
| 56 | MP0001919_abnormal_reproductive_system | 1.26056496 |
| 57 | MP0009384_cardiac_valve_regurgitation | 1.26010241 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.24496637 |
| 59 | MP0001835_abnormal_antigen_presentation | 1.23877703 |
| 60 | * MP0004264_abnormal_extraembryonic_tissu | 1.21948578 |
| 61 | MP0000681_abnormal_thyroid_gland | 1.19790579 |
| 62 | MP0005636_abnormal_mineral_homeostasis | 1.19345826 |
| 63 | MP0000377_abnormal_hair_follicle | 1.18380235 |
| 64 | MP0000678_abnormal_parathyroid_gland | 1.18187053 |
| 65 | MP0001849_ear_inflammation | 1.17769038 |
| 66 | MP0004185_abnormal_adipocyte_glucose | 1.14968221 |
| 67 | MP0001764_abnormal_homeostasis | 1.12012286 |
| 68 | MP0000003_abnormal_adipose_tissue | 1.11264764 |
| 69 | MP0001216_abnormal_epidermal_layer | 1.11086166 |
| 70 | MP0008469_abnormal_protein_level | 1.09924681 |
| 71 | MP0009278_abnormal_bone_marrow | 1.09564017 |
| 72 | MP0000470_abnormal_stomach_morphology | 1.08957975 |
| 73 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07932198 |
| 74 | MP0001879_abnormal_lymphatic_vessel | 1.06690737 |
| 75 | MP0001845_abnormal_inflammatory_respons | 1.05802362 |
| 76 | MP0002928_abnormal_bile_duct | 1.04611394 |
| 77 | MP0003186_abnormal_redox_activity | 1.04381343 |
| 78 | MP0003941_abnormal_skin_development | 1.04304714 |
| 79 | MP0001664_abnormal_digestion | 1.03509827 |
| 80 | MP0000858_altered_metastatic_potential | 1.03201673 |
| 81 | MP0004043_abnormal_pH_regulation | 1.03162605 |
| 82 | MP0001533_abnormal_skeleton_physiology | 1.03014674 |
| 83 | * MP0000598_abnormal_liver_morphology | 1.02234267 |
| 84 | MP0004233_abnormal_muscle_weight | 1.01587862 |
| 85 | MP0001756_abnormal_urination | 1.01497882 |
| 86 | MP0005646_abnormal_pituitary_gland | 0.99957713 |
| 87 | MP0008995_early_reproductive_senescence | 0.99662580 |
| 88 | MP0000538_abnormal_urinary_bladder | 0.99222377 |
| 89 | MP0000490_abnormal_crypts_of | 0.99055700 |
| 90 | MP0002254_reproductive_system_inflammat | 0.98920744 |
| 91 | MP0002160_abnormal_reproductive_system | 0.98191247 |
| 92 | MP0004947_skin_inflammation | 0.97661716 |
| 93 | MP0000427_abnormal_hair_cycle | 0.97119821 |
| 94 | MP0000477_abnormal_intestine_morphology | 0.96758638 |
| 95 | MP0005075_abnormal_melanosome_morpholog | 0.96278395 |
| 96 | MP0000467_abnormal_esophagus_morphology | 0.96122579 |
| 97 | MP0009780_abnormal_chondrocyte_physiolo | 0.96077947 |
| 98 | MP0004130_abnormal_muscle_cell | 0.95947537 |
| 99 | MP0003172_abnormal_lysosome_physiology | 0.95445975 |
| 100 | MP0001873_stomach_inflammation | 0.94928736 |
| 101 | MP0003936_abnormal_reproductive_system | 0.94900551 |
| 102 | MP0005670_abnormal_white_adipose | 0.94026586 |
| 103 | MP0004808_abnormal_hematopoietic_stem | 0.93679757 |
| 104 | MP0008438_abnormal_cutaneous_collagen | 0.93589602 |
| 105 | MP0003566_abnormal_cell_adhesion | 0.92893581 |
| 106 | MP0008260_abnormal_autophagy | 0.92849176 |
| 107 | MP0001765_abnormal_ion_homeostasis | 0.92655931 |
| 108 | MP0010155_abnormal_intestine_physiology | 0.92623042 |
| 109 | MP0003638_abnormal_response/metabolism_ | 0.92548057 |
| 110 | MP0002166_altered_tumor_susceptibility | 0.92547735 |
| 111 | MP0002277_abnormal_respiratory_mucosa | 0.89959001 |
| 112 | MP0005464_abnormal_platelet_physiology | 0.89648572 |
| 113 | MP0004782_abnormal_surfactant_physiolog | 0.88969865 |
| 114 | MP0009333_abnormal_splenocyte_physiolog | 0.88694460 |
| 115 | MP0009642_abnormal_blood_homeostasis | 0.88366436 |
| 116 | MP0003959_abnormal_lean_body | 0.88147067 |
| 117 | MP0002419_abnormal_innate_immunity | 0.86071801 |
| 118 | MP0002396_abnormal_hematopoietic_system | 0.85363996 |
| 119 | * MP0009931_abnormal_skin_appearance | 0.84634266 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.83339445 |
| 121 | MP0000465_gastrointestinal_hemorrhage | 0.83322957 |
| 122 | MP0002876_abnormal_thyroid_physiology | 0.83283176 |
| 123 | MP0009763_increased_sensitivity_to | 0.83068228 |
| 124 | MP0005387_immune_system_phenotype | 0.82792102 |
| 125 | MP0001790_abnormal_immune_system | 0.82792102 |
| 126 | MP0005025_abnormal_response_to | 0.81408984 |
| 127 | MP0003283_abnormal_digestive_organ | 0.81403531 |
| 128 | MP0009785_altered_susceptibility_to | 0.81169377 |
| 129 | MP0000685_abnormal_immune_system | 0.80766558 |
| 130 | MP0002089_abnormal_postnatal_growth/wei | 0.80294712 |
| 131 | MP0005409_darkened_coat_color | 0.80015715 |
| 132 | MP0002136_abnormal_kidney_physiology | 0.79834029 |
| 133 | MP0009764_decreased_sensitivity_to | 0.79411429 |
| 134 | MP0008961_abnormal_basal_metabolism | 0.78941403 |
| 135 | MP0005000_abnormal_immune_tolerance | 0.78602863 |
| 136 | MP0005334_abnormal_fat_pad | 0.77964352 |
| 137 | MP0002896_abnormal_bone_mineralization | 0.77868532 |
| 138 | MP0001542_abnormal_bone_strength | 0.77369405 |
| 139 | MP0009672_abnormal_birth_weight | 0.76877697 |
| 140 | MP0010352_gastrointestinal_tract_polyps | 0.75189668 |
| 141 | MP0010386_abnormal_urinary_bladder | 0.74846944 |
| 142 | MP0008004_abnormal_stomach_pH | 0.74172217 |
| 143 | MP0002971_abnormal_brown_adipose | 0.72268540 |
| 144 | MP0005448_abnormal_energy_balance | 0.72240547 |
| 145 | MP0003656_abnormal_erythrocyte_physiolo | 0.71936767 |
| 146 | MP0003953_abnormal_hormone_level | 0.70934423 |
| 147 | MP0002933_joint_inflammation | 0.70779166 |
| 148 | MP0002060_abnormal_skin_morphology | 0.69158961 |
| 149 | MP0005023_abnormal_wound_healing | 0.68392860 |
| 150 | MP0002796_impaired_skin_barrier | 0.67566116 |
| 151 | MP0003866_abnormal_defecation | 0.66841191 |
| 152 | MP0005666_abnormal_adipose_tissue | 0.66432717 |
| 153 | MP0000604_amyloidosis | 0.65715747 |
| 154 | MP0001661_extended_life_span | 0.65012336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | J-shaped sella turcica (HP:0002680) | 4.98681598 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.84838899 |
| 3 | Asymmetry of the thorax (HP:0001555) | 4.81217344 |
| 4 | Hypoglycemic coma (HP:0001325) | 4.72880697 |
| 5 | Abnormality of the intrinsic pathway (HP:0010989) | 4.21339365 |
| 6 | Deep venous thrombosis (HP:0002625) | 4.07696302 |
| 7 | Flat acetabular roof (HP:0003180) | 4.07588154 |
| 8 | Xanthomatosis (HP:0000991) | 3.98028387 |
| 9 | Hypoglycemic seizures (HP:0002173) | 3.95255233 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 3.95046001 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 3.89038214 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.79116656 |
| 13 | Ketoacidosis (HP:0001993) | 3.75138053 |
| 14 | Concave nail (HP:0001598) | 3.68117264 |
| 15 | Ketosis (HP:0001946) | 3.65790035 |
| 16 | Septate vagina (HP:0001153) | 3.61836701 |
| 17 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.60909523 |
| 18 | Absent frontal sinuses (HP:0002688) | 3.46957631 |
| 19 | Complement deficiency (HP:0004431) | 3.45669978 |
| 20 | Sparse lateral eyebrow (HP:0005338) | 3.42170605 |
| 21 | Prolonged partial thromboplastin time (HP:0003645) | 3.35219672 |
| 22 | Gout (HP:0001997) | 3.24954432 |
| 23 | Late onset (HP:0003584) | 3.22721849 |
| 24 | Symptomatic seizures (HP:0011145) | 3.20220477 |
| 25 | Mucopolysacchariduria (HP:0008155) | 3.11525113 |
| 26 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.11525113 |
| 27 | Fat malabsorption (HP:0002630) | 3.07991821 |
| 28 | Vacuolated lymphocytes (HP:0001922) | 3.04716909 |
| 29 | Dysostosis multiplex (HP:0000943) | 3.00682546 |
| 30 | Thin bony cortex (HP:0002753) | 2.94977040 |
| 31 | Hyperglycemia (HP:0003074) | 2.93034258 |
| 32 | Hypobetalipoproteinemia (HP:0003563) | 2.92801624 |
| 33 | Breast carcinoma (HP:0003002) | 2.92754685 |
| 34 | Abnormality of purine metabolism (HP:0004352) | 2.90967339 |
| 35 | Testicular neoplasm (HP:0010788) | 2.88230080 |
| 36 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.86088926 |
| 37 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.86088926 |
| 38 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.84039891 |
| 39 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.84039891 |
| 40 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.84039891 |
| 41 | Hyperlipoproteinemia (HP:0010980) | 2.82896749 |
| 42 | Deformed sella turcica (HP:0002681) | 2.81575814 |
| 43 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.80194444 |
| 44 | Joint hemorrhage (HP:0005261) | 2.79533344 |
| 45 | Conjugated hyperbilirubinemia (HP:0002908) | 2.79016457 |
| 46 | Generalized aminoaciduria (HP:0002909) | 2.73615691 |
| 47 | Abnormality of complement system (HP:0005339) | 2.70666856 |
| 48 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.68572005 |
| 49 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.68220827 |
| 50 | Germ cell neoplasia (HP:0100728) | 2.65505141 |
| 51 | Myocardial infarction (HP:0001658) | 2.59044791 |
| 52 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.56205292 |
| 53 | Hypolipoproteinemia (HP:0010981) | 2.54404862 |
| 54 | Right ventricular cardiomyopathy (HP:0011663) | 2.54185630 |
| 55 | Distal lower limb muscle weakness (HP:0009053) | 2.51180740 |
| 56 | Hypoalphalipoproteinemia (HP:0003233) | 2.49240762 |
| 57 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.49127177 |
| 58 | Hyperparathyroidism (HP:0000843) | 2.48372582 |
| 59 | Hyperammonemia (HP:0001987) | 2.47355800 |
| 60 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.45905163 |
| 61 | Systemic lupus erythematosus (HP:0002725) | 2.45853556 |
| 62 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.45755795 |
| 63 | Nasal polyposis (HP:0100582) | 2.45083722 |
| 64 | Chronic bronchitis (HP:0004469) | 2.44055009 |
| 65 | Steatorrhea (HP:0002570) | 2.43926299 |
| 66 | Interstitial pulmonary disease (HP:0006530) | 2.41554900 |
| 67 | Abnormality of the frontal sinuses (HP:0002687) | 2.38313897 |
| 68 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.36594461 |
| 69 | Abnormality of nucleobase metabolism (HP:0010932) | 2.35658376 |
| 70 | Insulin resistance (HP:0000855) | 2.34108543 |
| 71 | Protuberant abdomen (HP:0001538) | 2.32475415 |
| 72 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.31305068 |
| 73 | Amelogenesis imperfecta (HP:0000705) | 2.30702972 |
| 74 | Pili torti (HP:0003777) | 2.30536763 |
| 75 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.30318233 |
| 76 | Abdominal distention (HP:0003270) | 2.29876188 |
| 77 | Microglossia (HP:0000171) | 2.29724686 |
| 78 | Curly hair (HP:0002212) | 2.29635049 |
| 79 | Epidermoid cyst (HP:0200040) | 2.29204054 |
| 80 | Testicular atrophy (HP:0000029) | 2.27053961 |
| 81 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.26870531 |
| 82 | Syringomyelia (HP:0003396) | 2.26614606 |
| 83 | Spinal cord lesions (HP:0100561) | 2.26614606 |
| 84 | Long toe (HP:0010511) | 2.25332701 |
| 85 | Pancreatitis (HP:0001733) | 2.24365687 |
| 86 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.22297323 |
| 87 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.21704636 |
| 88 | Esophageal varix (HP:0002040) | 2.18463788 |
| 89 | Flattened epiphyses (HP:0003071) | 2.16419972 |
| 90 | Micronodular cirrhosis (HP:0001413) | 2.16180140 |
| 91 | Eczematoid dermatitis (HP:0000976) | 2.16172671 |
| 92 | Hyperglycinuria (HP:0003108) | 2.16135794 |
| 93 | Spinal cord compression (HP:0002176) | 2.15123016 |
| 94 | Hyperactive renin-angiotensin system (HP:0000841) | 2.14629464 |
| 95 | Hyperbilirubinemia (HP:0002904) | 2.13915657 |
| 96 | Bronchitis (HP:0012387) | 2.11791984 |
| 97 | Skin nodule (HP:0200036) | 2.11158644 |
| 98 | Mitral stenosis (HP:0001718) | 2.10692477 |
| 99 | Abnormality of the nasal mucosa (HP:0000433) | 2.10308263 |
| 100 | Abnormal foot bone ossification (HP:0010675) | 2.09086773 |
| 101 | Vascular calcification (HP:0004934) | 2.07939855 |
| 102 | Villous atrophy (HP:0011473) | 2.07553235 |
| 103 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.07553235 |
| 104 | Malnutrition (HP:0004395) | 2.05494630 |
| 105 | Colitis (HP:0002583) | 2.04611508 |
| 106 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.02001166 |
| 107 | Growth hormone excess (HP:0000845) | 2.00007823 |
| 108 | Macroorchidism (HP:0000053) | 1.99939407 |
| 109 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.99770462 |
| 110 | Bronchiectasis (HP:0002110) | 1.99429384 |
| 111 | Congenital glaucoma (HP:0001087) | 1.98128676 |
| 112 | Nonimmune hydrops fetalis (HP:0001790) | 1.98002364 |
| 113 | Enlarged penis (HP:0000040) | 1.96180008 |
| 114 | Hypoparathyroidism (HP:0000829) | 1.95833059 |
| 115 | Seborrheic dermatitis (HP:0001051) | 1.95256368 |
| 116 | Cardiovascular calcification (HP:0011915) | 1.94089160 |
| 117 | Rhinitis (HP:0012384) | 1.93825987 |
| 118 | Abnormal tarsal ossification (HP:0008369) | 1.92674555 |
| 119 | Vertebral compression fractures (HP:0002953) | 1.92161320 |
| 120 | Glomerulonephritis (HP:0000099) | 1.91984087 |
| 121 | Recurrent bronchitis (HP:0002837) | 1.89611155 |
| 122 | Abnormality of glycine metabolism (HP:0010895) | 1.89534939 |
| 123 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.89534939 |
| 124 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.89525785 |
| 125 | Menorrhagia (HP:0000132) | 1.89521650 |
| 126 | Hemorrhage of the eye (HP:0011885) | 1.89409660 |
| 127 | Abnormality of nail color (HP:0100643) | 1.89368524 |
| 128 | Hydroxyprolinuria (HP:0003080) | 1.89229005 |
| 129 | Abnormality of proline metabolism (HP:0010907) | 1.89229005 |
| 130 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89047313 |
| 131 | Lymphangioma (HP:0100764) | 1.88994011 |
| 132 | Hepatocellular carcinoma (HP:0001402) | 1.88604496 |
| 133 | Hyperglycinemia (HP:0002154) | 1.88541572 |
| 134 | Retinal atrophy (HP:0001105) | 1.88344446 |
| 135 | Abnormality of the gastric mucosa (HP:0004295) | 1.87173587 |
| 136 | Hypercholesterolemia (HP:0003124) | 1.86656136 |
| 137 | Cervical subluxation (HP:0003308) | 1.85216866 |
| 138 | Abnormality of the thoracic spine (HP:0100711) | 1.84716115 |
| 139 | Abnormal hair laboratory examination (HP:0003328) | 1.84534982 |
| 140 | Lip pit (HP:0100267) | 1.84355875 |
| 141 | Deep philtrum (HP:0002002) | 1.82462431 |
| 142 | Cone-rod dystrophy (HP:0000548) | 1.82438386 |
| 143 | Back pain (HP:0003418) | 1.82307631 |
| 144 | Hyperuricemia (HP:0002149) | 1.81699741 |
| 145 | Increased purine levels (HP:0004368) | 1.81699741 |
| 146 | Increased serum ferritin (HP:0003281) | 1.80551180 |
| 147 | B lymphocytopenia (HP:0010976) | 1.80505086 |
| 148 | Elevated alkaline phosphatase (HP:0003155) | 1.80383301 |
| 149 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.80257272 |
| 150 | Exostoses (HP:0100777) | 1.79344217 |
| 151 | Recurrent otitis media (HP:0000403) | 1.79229897 |
| 152 | Bone pain (HP:0002653) | 1.78891331 |
| 153 | Gingival bleeding (HP:0000225) | 1.78687941 |
| 154 | Agammaglobulinemia (HP:0004432) | 1.78656301 |
| 155 | Hypophosphatemia (HP:0002148) | 1.76885954 |
| 156 | Increased cerebral lipofuscin (HP:0011813) | 1.76838468 |
| 157 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.76800941 |
| 158 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.76758443 |
| 159 | Dicarboxylic aciduria (HP:0003215) | 1.76758443 |
| 160 | Cardiomegaly (HP:0001640) | 1.76278364 |
| 161 | Reduced antithrombin III activity (HP:0001976) | 1.76278051 |
| 162 | Irritability (HP:0000737) | 1.75023979 |
| 163 | Beaking of vertebral bodies (HP:0004568) | 1.74473314 |
| 164 | Hypercortisolism (HP:0001578) | 1.73719459 |
| 165 | Myoglobinuria (HP:0002913) | 1.73246432 |
| 166 | Abnormal pancreas size (HP:0012094) | 1.71913852 |
| 167 | Gastrointestinal inflammation (HP:0004386) | 1.71106232 |
| 168 | Abnormality of the umbilical cord (HP:0010881) | 1.70918319 |
| 169 | Inflammation of the large intestine (HP:0002037) | 1.70176724 |
| 170 | Abnormal cartilage morphology (HP:0002763) | 1.69864559 |
| 171 | Stroke (HP:0001297) | 1.69826546 |
| 172 | Large for gestational age (HP:0001520) | 1.69362806 |
| 173 | Metabolic acidosis (HP:0001942) | 1.68708484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 6.52905957 |
| 2 | BCKDK | 3.93526277 |
| 3 | TRIB3 | 3.23006586 |
| 4 | TAOK3 | 3.17156730 |
| 5 | SIK1 | 3.01435942 |
| 6 | INSRR | 2.83138202 |
| 7 | FLT3 | 2.72246266 |
| 8 | PKN2 | 2.56723170 |
| 9 | SMG1 | 2.40951423 |
| 10 | KDR | 2.32629095 |
| 11 | MAPK15 | 2.22349458 |
| 12 | FGFR4 | 2.21483850 |
| 13 | MUSK | 1.99281838 |
| 14 | FRK | 1.90600783 |
| 15 | PTK6 | 1.89432364 |
| 16 | EPHA3 | 1.84965158 |
| 17 | RIPK1 | 1.67435503 |
| 18 | TYK2 | 1.62897472 |
| 19 | NEK6 | 1.60156158 |
| 20 | TBK1 | 1.60094229 |
| 21 | NME2 | 1.60090036 |
| 22 | EPHB1 | 1.60019620 |
| 23 | PASK | 1.58764340 |
| 24 | IRAK3 | 1.54895404 |
| 25 | SCYL2 | 1.50628079 |
| 26 | TGFBR2 | 1.48845018 |
| 27 | ZAP70 | 1.46549525 |
| 28 | PIK3CG | 1.42302496 |
| 29 | MAPKAPK3 | 1.39387641 |
| 30 | MAP3K12 | 1.36978352 |
| 31 | TESK2 | 1.36824004 |
| 32 | JAK3 | 1.26286071 |
| 33 | MAP2K3 | 1.23614096 |
| 34 | JAK1 | 1.22174442 |
| 35 | MAP4K1 | 1.21776636 |
| 36 | MAP3K3 | 1.21439112 |
| 37 | EIF2AK3 | 1.21244059 |
| 38 | HIPK2 | 1.20825329 |
| 39 | MAP3K2 | 1.20581910 |
| 40 | PRPF4B | 1.19037457 |
| 41 | EIF2AK1 | 1.10748104 |
| 42 | MST1R | 1.09966991 |
| 43 | CDK7 | 1.09504432 |
| 44 | MAP2K2 | 1.09273638 |
| 45 | TIE1 | 1.07830741 |
| 46 | EEF2K | 1.06133860 |
| 47 | JAK2 | 1.04302427 |
| 48 | MAP3K1 | 1.01200494 |
| 49 | RPS6KA2 | 1.00557594 |
| 50 | CAMK1D | 0.97796952 |
| 51 | IRAK4 | 0.95893799 |
| 52 | ILK | 0.95774952 |
| 53 | PIM2 | 0.93419377 |
| 54 | NEK9 | 0.92952967 |
| 55 | PRKCI | 0.91434964 |
| 56 | ICK | 0.90745968 |
| 57 | PTK2 | 0.89276077 |
| 58 | PDGFRA | 0.88207074 |
| 59 | RPS6KB1 | 0.87575325 |
| 60 | BTK | 0.84300576 |
| 61 | FGFR3 | 0.83562744 |
| 62 | IRAK1 | 0.83394991 |
| 63 | RPS6KC1 | 0.82143434 |
| 64 | RPS6KL1 | 0.82143434 |
| 65 | MET | 0.81681300 |
| 66 | LRRK2 | 0.80687891 |
| 67 | IKBKE | 0.79848352 |
| 68 | CSK | 0.76767480 |
| 69 | FER | 0.76164092 |
| 70 | TEC | 0.73030877 |
| 71 | CDK12 | 0.72709916 |
| 72 | MAP3K14 | 0.72443330 |
| 73 | RET | 0.72329393 |
| 74 | MAPK11 | 0.70769146 |
| 75 | IKBKB | 0.68804530 |
| 76 | EPHA2 | 0.68239395 |
| 77 | SIK3 | 0.67704929 |
| 78 | MAP3K10 | 0.67496779 |
| 79 | KIT | 0.66584969 |
| 80 | MAPKAPK2 | 0.65585022 |
| 81 | RPS6KA6 | 0.64624753 |
| 82 | WNK4 | 0.62751936 |
| 83 | TAOK1 | 0.62068096 |
| 84 | DYRK1B | 0.61772444 |
| 85 | TNK2 | 0.61578319 |
| 86 | WNK3 | 0.60812790 |
| 87 | MAP3K7 | 0.60806930 |
| 88 | ITK | 0.58525598 |
| 89 | BMPR2 | 0.57977544 |
| 90 | MAP3K11 | 0.55251253 |
| 91 | MATK | 0.55169360 |
| 92 | CSF1R | 0.54656624 |
| 93 | PRKG2 | 0.53916960 |
| 94 | CAMKK2 | 0.53622549 |
| 95 | LATS1 | 0.52851837 |
| 96 | NLK | 0.52046586 |
| 97 | YES1 | 0.50059130 |
| 98 | BLK | 0.49263083 |
| 99 | MAP2K1 | 0.48524574 |
| 100 | PDGFRB | 0.47971865 |
| 101 | CHUK | 0.47860758 |
| 102 | RPS6KA4 | 0.47852891 |
| 103 | TAOK2 | 0.47478121 |
| 104 | TRPM7 | 0.47188106 |
| 105 | GSK3A | 0.46439798 |
| 106 | MYLK | 0.46111797 |
| 107 | PDK1 | 0.45778836 |
| 108 | LMTK2 | 0.42753092 |
| 109 | IGF1R | 0.42300755 |
| 110 | MST4 | 0.40514492 |
| 111 | NTRK1 | 0.40402846 |
| 112 | PRKAA2 | 0.39792289 |
| 113 | CAMK1G | 0.39524996 |
| 114 | MTOR | 0.38851129 |
| 115 | AKT2 | 0.38847811 |
| 116 | GRK6 | 0.38153238 |
| 117 | TESK1 | 0.38108139 |
| 118 | SYK | 0.37873457 |
| 119 | CDK6 | 0.36740564 |
| 120 | PIK3CA | 0.36597513 |
| 121 | CDK8 | 0.35915763 |
| 122 | PRKCH | 0.35642002 |
| 123 | PAK4 | 0.35527822 |
| 124 | RPS6KA1 | 0.33729950 |
| 125 | RPS6KB2 | 0.33243614 |
| 126 | PRKD1 | 0.31892951 |
| 127 | MAPK3 | 0.31458983 |
| 128 | CDC42BPA | 0.31427564 |
| 129 | EGFR | 0.30277998 |
| 130 | VRK2 | 0.29401694 |
| 131 | MAPK4 | 0.28903617 |
| 132 | PAK2 | 0.28733148 |
| 133 | DMPK | 0.28714173 |
| 134 | ERBB4 | 0.28442550 |
| 135 | PRKD2 | 0.28043792 |
| 136 | LYN | 0.27801910 |
| 137 | RIPK4 | 0.27257323 |
| 138 | PDPK1 | 0.27078894 |
| 139 | CAMKK1 | 0.27047871 |
| 140 | KSR2 | 0.26585948 |
| 141 | PRKAA1 | 0.25398924 |
| 142 | TGFBR1 | 0.25166563 |
| 143 | MAP2K6 | 0.24110651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.24013075 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.25250330 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.85605916 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.68513983 |
| 5 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.48475442 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.43140839 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.23743870 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.20438509 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.20280863 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.11864646 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.08421692 |
| 12 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.07548591 |
| 13 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.02941644 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.97749280 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.87009177 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.86026430 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.85343942 |
| 18 | Hepatitis C_Homo sapiens_hsa05160 | 1.77220053 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.71864868 |
| 20 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.64598855 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.58509564 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.57702268 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57450473 |
| 24 | Thyroid cancer_Homo sapiens_hsa05216 | 1.53562235 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.51879988 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.51810941 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.50224446 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.48476880 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.42480632 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.42322784 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.41574742 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.41389951 |
| 33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.40974785 |
| 34 | Endometrial cancer_Homo sapiens_hsa05213 | 1.39294146 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.34867895 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.34234556 |
| 37 | Galactose metabolism_Homo sapiens_hsa00052 | 1.31998349 |
| 38 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.31439039 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.28485014 |
| 40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.25986727 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.25864052 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.24772752 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.21480236 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.18719711 |
| 45 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.17903471 |
| 46 | Prostate cancer_Homo sapiens_hsa05215 | 1.17346943 |
| 47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.15949969 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 1.15786254 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15194999 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.14345098 |
| 51 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.12623530 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.09298526 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.07896090 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.04803477 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.00739109 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.00663962 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 1.00595814 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.00311672 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95948643 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 0.94462329 |
| 61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.94065763 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93766524 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.93524232 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93429844 |
| 65 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.93149252 |
| 66 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.91459140 |
| 67 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91325632 |
| 68 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89688740 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88690100 |
| 70 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88070391 |
| 71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85476110 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83777733 |
| 73 | Hepatitis B_Homo sapiens_hsa05161 | 0.83510700 |
| 74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.80061756 |
| 75 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78926653 |
| 76 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.77048044 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76321034 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75181739 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75170886 |
| 80 | Asthma_Homo sapiens_hsa05310 | 0.74703492 |
| 81 | Allograft rejection_Homo sapiens_hsa05330 | 0.72715921 |
| 82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.72562157 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71908226 |
| 84 | Measles_Homo sapiens_hsa05162 | 0.71105815 |
| 85 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71036792 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70556658 |
| 87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70294849 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69906360 |
| 89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68715339 |
| 90 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67837996 |
| 91 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67197116 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.65926779 |
| 93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65708822 |
| 94 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65096002 |
| 95 | Apoptosis_Homo sapiens_hsa04210 | 0.64946409 |
| 96 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64036496 |
| 97 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63185262 |
| 98 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.62277640 |
| 99 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.62249187 |
| 100 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61447656 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61281464 |
| 102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60887136 |
| 103 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60820634 |
| 104 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60086029 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59609899 |
| 106 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59126996 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57433399 |
| 108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56789913 |
| 109 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56660631 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.56563794 |
| 111 | Lysine degradation_Homo sapiens_hsa00310 | 0.56475875 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56249066 |
| 113 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55944836 |
| 114 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.55091051 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53097099 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52099936 |
| 117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51804703 |
| 118 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49584067 |
| 119 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.49466410 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49043755 |
| 121 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48453248 |
| 122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46863224 |
| 123 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45811454 |
| 124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.41558588 |
| 125 | Leishmaniasis_Homo sapiens_hsa05140 | 0.41391409 |
| 126 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41149196 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41015534 |
| 128 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.39339721 |
| 129 | Pertussis_Homo sapiens_hsa05133 | 0.35527704 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31087354 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30597564 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.28204589 |
| 133 | Bladder cancer_Homo sapiens_hsa05219 | 0.26824746 |
| 134 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26155947 |
| 135 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25221348 |
| 136 | Insulin secretion_Homo sapiens_hsa04911 | 0.24735349 |
| 137 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.24040464 |
| 138 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.24002243 |
| 139 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23798037 |
| 140 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21652460 |
| 141 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.21044896 |
| 142 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.20849256 |

